Pascal Soriot

It's a substantial investment on our side, but also our financial partners, we can help choose some of those investments but we can also help along the way the startup companies, develop products and find their way around the world.

(Bohen's) impressive expertise in key areas of our exciting pipeline, including oncology and immunology, will further strengthen and accelerate the delivery of new medicines for patients.

We made good progress in the period, delivering a robust underlyi... by Pascal Soriot

We made good progress in the period, delivering a robust underlying business performance.

Payers will try to leverage their strengths to try and get pricing concessions because those agents are very expensive.

Oncology is going to become rapidly a growth platform for us. by Pascal Soriot

Oncology is going to become rapidly a growth platform for us.

We're asking our shareholders to be patient, We cannot overnight replace (heartburn and cholesterol drugs) Nexium and Crestor. Those are tremendous products, they are very profitable and when they go they really leave a hole in the till.